A new human study involving 80 patients supports previous evidence that BioCell Collagen II from BioCell Technology LLC improves various physical activities of subjects suffering from joint conditions associated with osteoarthritis (OA).

This multi-center, double-blind, placebo-controlled trial indicated that a significant portion of OA patients experienced highly substantial improvement of their joint conditions, as measured by VAS and WOMAC scores. Qualitative and quantitative outcomes from this study indicate improvement in pain, stiffness, mobility and overall improvement in quality of life. Details of the study are expected to be published in the near future, according to the company. For further information: www.biocelltechnology.com